A detailed history of Bath Savings Trust CO transactions in Novo Nordisk A S stock. As of the latest transaction made, Bath Savings Trust CO holds 8,899 shares of NVO stock, worth $936,797. This represents 0.11% of its overall portfolio holdings.

Number of Shares
8,899
Previous 9,319 4.51%
Holding current value
$936,797
Previous $1.33 Million 20.38%
% of portfolio
0.11%
Previous 0.14%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$119.07 - $145.42 $50,009 - $61,076
-420 Reduced 4.51%
8,899 $1.06 Million
Q2 2024

Jul 12, 2024

SELL
$122.71 - $146.91 $17,792 - $21,301
-145 Reduced 1.53%
9,319 $1.33 Million
Q1 2024

Apr 08, 2024

SELL
$102.11 - $135.92 $153,165 - $203,879
-1,500 Reduced 13.68%
9,464 $1.22 Million
Q4 2023

Jan 09, 2024

SELL
$87.78 - $105.45 $14,308 - $17,188
-163 Reduced 1.46%
10,964 $1.13 Million
Q3 2023

Oct 12, 2023

BUY
$90.94 - $199.54 $502,716 - $1.1 Million
5,528 Added 98.73%
11,127 $1.01 Million
Q2 2023

Jul 12, 2023

SELL
$155.98 - $172.65 $9,358 - $10,359
-60 Reduced 1.06%
5,599 $906,000
Q1 2023

Apr 12, 2023

SELL
$132.34 - $159.14 $66,170 - $79,570
-500 Reduced 8.12%
5,659 $900,000
Q4 2022

Jan 12, 2023

SELL
$102.55 - $135.33 $7,691 - $10,149
-75 Reduced 1.2%
6,159 $834,000
Q3 2022

Oct 05, 2022

SELL
$95.28 - $116.93 $9,528 - $11,693
-100 Reduced 1.58%
6,234 $621,000
Q2 2022

Jul 07, 2022

SELL
$103.24 - $121.81 $5,162 - $6,090
-50 Reduced 0.78%
6,334 $706,000
Q1 2022

Apr 07, 2022

SELL
$93.1 - $112.54 $9,310 - $11,254
-100 Reduced 1.54%
6,384 $709,000
Q4 2021

Jan 03, 2022

SELL
$95.88 - $117.08 $1,917 - $2,341
-20 Reduced 0.31%
6,484 $726,000
Q3 2021

Oct 06, 2021

SELL
$84.42 - $106.62 $16,884 - $21,324
-200 Reduced 2.98%
6,504 $624,000
Q2 2021

Jul 07, 2021

SELL
$67.66 - $84.76 $10,149 - $12,714
-150 Reduced 2.19%
6,704 $562,000
Q1 2021

Apr 08, 2021

SELL
$67.06 - $75.82 $13,412 - $15,163
-200 Reduced 2.84%
6,854 $462,000
Q4 2020

Jan 13, 2021

SELL
$63.89 - $73.8 $1,597 - $1,845
-25 Reduced 0.35%
7,054 $493,000
Q3 2020

Oct 01, 2020

SELL
$63.69 - $70.22 $45,920 - $50,628
-721 Reduced 9.24%
7,079 $492,000
Q2 2020

Jul 06, 2020

SELL
$58.54 - $67.94 $1,697 - $1,970
-29 Reduced 0.37%
7,800 $511,000
Q1 2020

Apr 01, 2020

SELL
$49.46 - $64.78 $12,167 - $15,935
-246 Reduced 3.05%
7,829 $471,000
Q4 2019

Jan 09, 2020

SELL
$49.86 - $58.26 $3,739 - $4,369
-75 Reduced 0.92%
8,075 $468,000
Q3 2019

Oct 03, 2019

SELL
$47.54 - $53.43 $7,131 - $8,014
-150 Reduced 1.81%
8,150 $421,000
Q1 2019

Apr 02, 2019

SELL
$46.36 - $52.63 $31,293 - $35,525
-675 Reduced 7.52%
8,300 $435,000
Q4 2018

Jan 04, 2019

SELL
$41.54 - $47.25 $98,657 - $112,218
-2,375 Reduced 20.93%
8,975 $414,000
Q3 2018

Oct 05, 2018

SELL
$46.76 - $51.24 $142,618 - $156,282
-3,050 Reduced 21.18%
11,350 $535,000
Q2 2018

Jul 05, 2018

SELL
$44.29 - $50.42 $40,968 - $46,638
-925 Reduced 6.04%
14,400 $664,000
Q1 2018

Apr 03, 2018

SELL
$48.49 - $58.14 $52,126 - $62,500
-1,075 Reduced 6.55%
15,325 $755,000
Q3 2017

Oct 02, 2017

BUY
$41.15 - $49.22 $674,860 - $807,208
16,400
16,400 $790,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Bath Savings Trust CO Portfolio

Follow Bath Savings Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bath Savings Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bath Savings Trust CO with notifications on news.